VSee Health Inc. reports Q3 revenue of $4.0 million with net loss of $0.3 million

Reuters11-17
<a href="https://laohu8.com/S/VSEE">VSee Health</a> Inc. reports Q3 revenue of $4.0 million with net loss of $0.3 million

VSee Health Inc. reported total revenues of $4.0 million for the three months ended September 30, 2025, up from $3.4 million in the same period of 2024. For the nine months ended September 30, 2025, total revenues reached $10.7 million, compared to $6.7 million in 2024. The company recorded a net loss of $0.3 million for the quarter, significantly lower than the $53.9 million net loss in the prior-year quarter. For the nine-month period, net loss was $6.9 million, compared to $54.5 million in 2024. As of the latest quarter, cash stood at $0.5 million and total assets were $18.7 million. Key business developments included the full activation of a $10 million-plus Level 1 hospital teleradiology contract, AI-enabled documentation reducing clinician workload, and achieving FedRAMP High authorization, expanding access to federal telehealth opportunities. The Technology segment generated $6.1 million year-to-date, an 11% increase year-over-year, while the Telehealth segment contributed $4.6 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1102957) on November 17, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment